Illumina Body Map 2
Name | miRBASE accession |
---|---|
hsa-let-7a-5p
|
MIMAT0000062 |
hsa-let-7b-5p
|
MIMAT0000063 |
hsa-let-7c-5p
|
MIMAT0000064 |
hsa-let-7d-5p
|
MIMAT0000065 |
hsa-let-7e-5p
|
MIMAT0000066 |
hsa-let-7f-5p
|
MIMAT0000067 |
hsa-let-7g-5p
|
MIMAT0000414 |
hsa-let-7i-5p
|
MIMAT0000415 |
hsa-miR-98-5p
|
MIMAT0000096 |
hsa-miR-4458
|
MIMAT0018980 |
hsa-miR-4500
|
MIMAT0019036 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_+_77774897 | 2.72 |
ENST00000281030.2
|
THRSP
|
thyroid hormone responsive |
chr2_+_189839046 | 2.38 |
ENST00000304636.3
ENST00000317840.5 |
COL3A1
|
collagen, type III, alpha 1 |
chr17_-_48278983 | 2.30 |
ENST00000225964.5
|
COL1A1
|
collagen, type I, alpha 1 |
chr5_+_42423872 | 2.08 |
ENST00000230882.4
ENST00000357703.3 |
GHR
|
growth hormone receptor |
chr11_+_130318869 | 1.86 |
ENST00000299164.2
|
ADAMTS15
|
ADAM metallopeptidase with thrombospondin type 1 motif, 15 |
chr7_+_94023873 | 1.79 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
chr21_-_28338732 | 1.77 |
ENST00000284987.5
|
ADAMTS5
|
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
chr2_-_1748214 | 1.69 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr15_-_51630772 | 1.64 |
ENST00000557858.1
ENST00000558328.1 ENST00000396404.4 ENST00000561075.1 ENST00000405011.2 ENST00000559980.1 ENST00000453807.2 ENST00000396402.1 |
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1 |
chr17_+_8213590 | 1.63 |
ENST00000361926.3
|
ARHGEF15
|
Rho guanine nucleotide exchange factor (GEF) 15 |
chr9_-_129885010 | 1.52 |
ENST00000373425.3
|
ANGPTL2
|
angiopoietin-like 2 |
chrX_+_2746850 | 1.46 |
ENST00000381163.3
ENST00000338623.5 ENST00000542787.1 |
GYG2
|
glycogenin 2 |
chrX_+_105066524 | 1.45 |
ENST00000243300.9
ENST00000428173.2 |
NRK
|
Nik related kinase |
chr7_-_132261253 | 1.42 |
ENST00000321063.4
|
PLXNA4
|
plexin A4 |
chr4_-_174451370 | 1.30 |
ENST00000359562.4
|
HAND2
|
heart and neural crest derivatives expressed 2 |
chr9_+_101705893 | 1.25 |
ENST00000375001.3
|
COL15A1
|
collagen, type XV, alpha 1 |
chr11_-_86666427 | 1.25 |
ENST00000531380.1
|
FZD4
|
frizzled family receptor 4 |
chr13_+_110959598 | 1.23 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr14_+_24867992 | 1.22 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr11_-_10590238 | 1.16 |
ENST00000256178.3
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr12_-_102874416 | 1.11 |
ENST00000392904.1
ENST00000337514.6 |
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
chr17_+_34058639 | 1.09 |
ENST00000268864.3
|
RASL10B
|
RAS-like, family 10, member B |
chr6_-_53530474 | 1.08 |
ENST00000370905.3
|
KLHL31
|
kelch-like family member 31 |
chr2_-_190044480 | 1.08 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
chr14_-_52535712 | 1.02 |
ENST00000216286.5
ENST00000541773.1 |
NID2
|
nidogen 2 (osteonidogen) |
chr11_-_27494279 | 0.95 |
ENST00000379214.4
|
LGR4
|
leucine-rich repeat containing G protein-coupled receptor 4 |
chr1_-_115880852 | 0.94 |
ENST00000369512.2
|
NGF
|
nerve growth factor (beta polypeptide) |
chr17_+_8924837 | 0.94 |
ENST00000173229.2
|
NTN1
|
netrin 1 |
chr9_+_19408999 | 0.92 |
ENST00000340967.2
|
ACER2
|
alkaline ceramidase 2 |
chr8_-_37824442 | 0.91 |
ENST00000345060.3
|
ADRB3
|
adrenoceptor beta 3 |
chr6_-_31107127 | 0.90 |
ENST00000259845.4
|
PSORS1C2
|
psoriasis susceptibility 1 candidate 2 |
chr3_-_127542021 | 0.89 |
ENST00000434178.2
|
MGLL
|
monoglyceride lipase |
chr15_+_74466012 | 0.89 |
ENST00000249842.3
|
ISLR
|
immunoglobulin superfamily containing leucine-rich repeat |
chr1_-_92351769 | 0.88 |
ENST00000212355.4
|
TGFBR3
|
transforming growth factor, beta receptor III |
chr1_+_170632250 | 0.88 |
ENST00000367760.3
|
PRRX1
|
paired related homeobox 1 |
chr9_+_116917807 | 0.86 |
ENST00000356083.3
|
COL27A1
|
collagen, type XXVII, alpha 1 |
chr19_-_7293942 | 0.85 |
ENST00000341500.5
ENST00000302850.5 |
INSR
|
insulin receptor |
chr12_-_69326940 | 0.85 |
ENST00000549781.1
ENST00000548262.1 ENST00000551568.1 ENST00000548954.1 |
CPM
|
carboxypeptidase M |
chr1_-_156051789 | 0.83 |
ENST00000532414.2
|
MEX3A
|
mex-3 RNA binding family member A |
chr22_+_24115000 | 0.83 |
ENST00000215743.3
|
MMP11
|
matrix metallopeptidase 11 (stromelysin 3) |
chr9_-_16870704 | 0.83 |
ENST00000380672.4
ENST00000380667.2 ENST00000380666.2 ENST00000486514.1 |
BNC2
|
basonuclin 2 |
chr3_+_16216137 | 0.81 |
ENST00000339732.5
|
GALNT15
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
chr3_-_87040233 | 0.81 |
ENST00000398399.2
|
VGLL3
|
vestigial like 3 (Drosophila) |
chr12_-_59313270 | 0.80 |
ENST00000379141.4
|
LRIG3
|
leucine-rich repeats and immunoglobulin-like domains 3 |
chr8_+_74206829 | 0.79 |
ENST00000240285.5
|
RDH10
|
retinol dehydrogenase 10 (all-trans) |
chr5_+_38846101 | 0.78 |
ENST00000274276.3
|
OSMR
|
oncostatin M receptor |
chr15_-_50411412 | 0.78 |
ENST00000284509.6
|
ATP8B4
|
ATPase, class I, type 8B, member 4 |
chr6_-_35464727 | 0.78 |
ENST00000402886.3
|
TEAD3
|
TEA domain family member 3 |
chr17_+_1958388 | 0.77 |
ENST00000399849.3
|
HIC1
|
hypermethylated in cancer 1 |
chr12_+_103981044 | 0.72 |
ENST00000388887.2
|
STAB2
|
stabilin 2 |
chr8_-_122653630 | 0.72 |
ENST00000303924.4
|
HAS2
|
hyaluronan synthase 2 |
chr21_-_28217721 | 0.69 |
ENST00000284984.3
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
chr5_+_150157444 | 0.69 |
ENST00000526627.1
|
SMIM3
|
small integral membrane protein 3 |
chr3_+_49209023 | 0.69 |
ENST00000332780.2
|
KLHDC8B
|
kelch domain containing 8B |
chr15_-_37390482 | 0.69 |
ENST00000559085.1
ENST00000397624.3 |
MEIS2
|
Meis homeobox 2 |
chr7_+_3340989 | 0.68 |
ENST00000404826.2
ENST00000389531.3 |
SDK1
|
sidekick cell adhesion molecule 1 |
chr5_+_172261228 | 0.67 |
ENST00000393784.3
|
ERGIC1
|
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
chr2_-_158485387 | 0.67 |
ENST00000243349.8
|
ACVR1C
|
activin A receptor, type IC |
chr18_+_6834472 | 0.67 |
ENST00000581099.1
ENST00000419673.2 ENST00000531294.1 |
ARHGAP28
|
Rho GTPase activating protein 28 |
chr3_+_39851094 | 0.65 |
ENST00000302541.6
|
MYRIP
|
myosin VIIA and Rab interacting protein |
chr7_-_27205136 | 0.65 |
ENST00000396345.1
ENST00000343483.6 |
HOXA9
|
homeobox A9 |
chr2_-_161350305 | 0.64 |
ENST00000348849.3
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1 |
chrX_+_56259316 | 0.64 |
ENST00000468660.1
|
KLF8
|
Kruppel-like factor 8 |
chr1_+_153232160 | 0.64 |
ENST00000368742.3
|
LOR
|
loricrin |
chr2_-_27435125 | 0.64 |
ENST00000414408.1
ENST00000310574.3 |
SLC5A6
|
solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 |
chr16_+_447209 | 0.63 |
ENST00000382940.4
ENST00000219479.2 |
NME4
|
NME/NM23 nucleoside diphosphate kinase 4 |
chr17_-_42908155 | 0.63 |
ENST00000426548.1
ENST00000590758.1 ENST00000591424.1 |
GJC1
|
gap junction protein, gamma 1, 45kDa |
chr5_-_41510656 | 0.63 |
ENST00000377801.3
|
PLCXD3
|
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
chr16_-_11350036 | 0.62 |
ENST00000332029.2
|
SOCS1
|
suppressor of cytokine signaling 1 |
chr16_+_22217577 | 0.61 |
ENST00000263026.5
|
EEF2K
|
eukaryotic elongation factor-2 kinase |
chr12_+_50690489 | 0.61 |
ENST00000598429.1
|
AC140061.12
|
Uncharacterized protein |
chr20_-_46415297 | 0.60 |
ENST00000467815.1
ENST00000359930.4 |
SULF2
|
sulfatase 2 |
chrX_+_49687216 | 0.59 |
ENST00000376088.3
|
CLCN5
|
chloride channel, voltage-sensitive 5 |
chr6_+_41606176 | 0.59 |
ENST00000441667.1
ENST00000230321.6 ENST00000373050.4 ENST00000446650.1 ENST00000435476.1 |
MDFI
|
MyoD family inhibitor |
chr7_-_138720763 | 0.59 |
ENST00000275766.1
|
ZC3HAV1L
|
zinc finger CCCH-type, antiviral 1-like |
chrX_-_107681633 | 0.58 |
ENST00000394872.2
ENST00000334504.7 |
COL4A6
|
collagen, type IV, alpha 6 |
chr13_-_110959478 | 0.58 |
ENST00000543140.1
ENST00000375820.4 |
COL4A1
|
collagen, type IV, alpha 1 |
chr7_+_120628731 | 0.57 |
ENST00000310396.5
|
CPED1
|
cadherin-like and PC-esterase domain containing 1 |
chr10_+_73724123 | 0.57 |
ENST00000373115.4
|
CHST3
|
carbohydrate (chondroitin 6) sulfotransferase 3 |
chr1_-_204121013 | 0.57 |
ENST00000367201.3
|
ETNK2
|
ethanolamine kinase 2 |
chr3_-_79068594 | 0.56 |
ENST00000436010.2
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
chr9_+_109625378 | 0.56 |
ENST00000277225.5
ENST00000457913.1 ENST00000472574.1 |
ZNF462
|
zinc finger protein 462 |
chr15_+_39873268 | 0.56 |
ENST00000397591.2
ENST00000260356.5 |
THBS1
|
thrombospondin 1 |
chr3_-_49459878 | 0.56 |
ENST00000546031.1
ENST00000458307.2 ENST00000430521.1 |
AMT
|
aminomethyltransferase |
chr5_+_150157860 | 0.56 |
ENST00000600109.1
|
AC010441.1
|
AC010441.1 |
chr2_-_230933709 | 0.55 |
ENST00000436869.1
ENST00000295190.4 |
SLC16A14
|
solute carrier family 16, member 14 |
chr10_+_101419187 | 0.55 |
ENST00000370489.4
|
ENTPD7
|
ectonucleoside triphosphate diphosphohydrolase 7 |
chr3_+_194406603 | 0.54 |
ENST00000329759.4
|
FAM43A
|
family with sequence similarity 43, member A |
chr12_-_65146636 | 0.54 |
ENST00000418919.2
|
GNS
|
glucosamine (N-acetyl)-6-sulfatase |
chr1_+_203595903 | 0.54 |
ENST00000367218.3
ENST00000367219.3 ENST00000391954.2 |
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
chr13_-_30881621 | 0.54 |
ENST00000380615.3
|
KATNAL1
|
katanin p60 subunit A-like 1 |
chr12_+_1800179 | 0.53 |
ENST00000357103.4
|
ADIPOR2
|
adiponectin receptor 2 |
chr11_+_36589547 | 0.53 |
ENST00000299440.5
|
RAG1
|
recombination activating gene 1 |
chr7_-_106301405 | 0.50 |
ENST00000523505.1
|
CCDC71L
|
coiled-coil domain containing 71-like |
chr1_-_28503693 | 0.49 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
chr1_+_230202936 | 0.49 |
ENST00000366672.4
|
GALNT2
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
chr7_+_90032667 | 0.49 |
ENST00000496677.1
ENST00000287916.4 ENST00000535571.1 ENST00000394604.1 ENST00000394605.2 |
CLDN12
|
claudin 12 |
chr8_+_70378852 | 0.48 |
ENST00000525061.1
ENST00000458141.2 ENST00000260128.4 |
SULF1
|
sulfatase 1 |
chr2_-_164592497 | 0.47 |
ENST00000333129.3
ENST00000409634.1 |
FIGN
|
fidgetin |
chr6_-_32157947 | 0.46 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
chr5_+_65440032 | 0.46 |
ENST00000334121.6
|
SREK1
|
splicing regulatory glutamine/lysine-rich protein 1 |
chr1_-_206945830 | 0.45 |
ENST00000423557.1
|
IL10
|
interleukin 10 |
chr5_-_32313019 | 0.44 |
ENST00000280285.5
ENST00000264934.5 |
MTMR12
|
myotubularin related protein 12 |
chr1_+_32645269 | 0.44 |
ENST00000373610.3
|
TXLNA
|
taxilin alpha |
chrX_-_33146477 | 0.44 |
ENST00000378677.2
|
DMD
|
dystrophin |
chr3_-_101039402 | 0.44 |
ENST00000193391.7
|
IMPG2
|
interphotoreceptor matrix proteoglycan 2 |
chr15_-_83474806 | 0.43 |
ENST00000541889.1
ENST00000334574.8 ENST00000561368.1 |
FSD2
|
fibronectin type III and SPRY domain containing 2 |
chr4_-_87770416 | 0.43 |
ENST00000273905.6
|
SLC10A6
|
solute carrier family 10 (sodium/bile acid cotransporter), member 6 |
chr3_+_184097836 | 0.43 |
ENST00000204604.1
ENST00000310236.3 |
CHRD
|
chordin |
chr9_+_118916082 | 0.43 |
ENST00000328252.3
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1 |
chr13_+_39612442 | 0.43 |
ENST00000470258.1
ENST00000379600.3 |
NHLRC3
|
NHL repeat containing 3 |
chrX_+_16804544 | 0.42 |
ENST00000380122.5
ENST00000398155.4 |
TXLNG
|
taxilin gamma |
chr2_+_11674213 | 0.42 |
ENST00000381486.2
|
GREB1
|
growth regulation by estrogen in breast cancer 1 |
chr12_+_56511943 | 0.42 |
ENST00000257940.2
ENST00000552345.1 ENST00000551880.1 ENST00000546903.1 ENST00000551790.1 |
ZC3H10
ESYT1
|
zinc finger CCCH-type containing 10 extended synaptotagmin-like protein 1 |
chr13_-_33859819 | 0.41 |
ENST00000336934.5
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13 |
chr13_+_98794810 | 0.41 |
ENST00000595437.1
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
chr16_-_20911641 | 0.40 |
ENST00000564349.1
ENST00000324344.4 |
ERI2
DCUN1D3
|
ERI1 exoribonuclease family member 2 DCN1, defective in cullin neddylation 1, domain containing 3 |
chr18_+_18943554 | 0.40 |
ENST00000580732.2
|
GREB1L
|
growth regulation by estrogen in breast cancer-like |
chr12_+_56862301 | 0.40 |
ENST00000338146.5
|
SPRYD4
|
SPRY domain containing 4 |
chrX_-_117250740 | 0.40 |
ENST00000371882.1
ENST00000540167.1 ENST00000545703.1 |
KLHL13
|
kelch-like family member 13 |
chr8_+_121137333 | 0.40 |
ENST00000309791.4
ENST00000297848.3 ENST00000247781.3 |
COL14A1
|
collagen, type XIV, alpha 1 |
chr1_-_177939041 | 0.40 |
ENST00000308284.6
|
SEC16B
|
SEC16 homolog B (S. cerevisiae) |
chr8_-_13372395 | 0.39 |
ENST00000276297.4
ENST00000511869.1 |
DLC1
|
deleted in liver cancer 1 |
chr6_+_143929307 | 0.39 |
ENST00000427704.2
ENST00000305766.6 |
PHACTR2
|
phosphatase and actin regulator 2 |
chr11_+_69455855 | 0.39 |
ENST00000227507.2
ENST00000536559.1 |
CCND1
|
cyclin D1 |
chr2_+_12857015 | 0.39 |
ENST00000155926.4
|
TRIB2
|
tribbles pseudokinase 2 |
chr6_+_125283566 | 0.38 |
ENST00000521654.2
|
RNF217
|
ring finger protein 217 |
chr1_-_9189229 | 0.38 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
chr4_+_56815102 | 0.38 |
ENST00000257287.4
|
CEP135
|
centrosomal protein 135kDa |
chr4_+_159690218 | 0.38 |
ENST00000264433.6
|
FNIP2
|
folliculin interacting protein 2 |
chr15_+_36887069 | 0.38 |
ENST00000566807.1
ENST00000567389.1 ENST00000562877.1 |
C15orf41
|
chromosome 15 open reading frame 41 |
chr1_+_29563011 | 0.37 |
ENST00000345512.3
ENST00000373779.3 ENST00000356870.3 ENST00000323874.8 ENST00000428026.2 ENST00000460170.2 |
PTPRU
|
protein tyrosine phosphatase, receptor type, U |
chr2_+_128848881 | 0.37 |
ENST00000259253.6
|
UGGT1
|
UDP-glucose glycoprotein glucosyltransferase 1 |
chr3_+_89156674 | 0.37 |
ENST00000336596.2
|
EPHA3
|
EPH receptor A3 |
chr1_-_108742957 | 0.37 |
ENST00000565488.1
|
SLC25A24
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 |
chr19_+_46800289 | 0.37 |
ENST00000377670.4
|
HIF3A
|
hypoxia inducible factor 3, alpha subunit |
chr12_+_56915713 | 0.37 |
ENST00000262031.5
ENST00000552247.2 |
RBMS2
|
RNA binding motif, single stranded interacting protein 2 |
chr2_+_128458514 | 0.36 |
ENST00000310981.4
|
SFT2D3
|
SFT2 domain containing 3 |
chr2_+_99953816 | 0.36 |
ENST00000289371.6
|
EIF5B
|
eukaryotic translation initiation factor 5B |
chr1_+_12227035 | 0.36 |
ENST00000376259.3
ENST00000536782.1 |
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B |
chr14_+_45366472 | 0.36 |
ENST00000325192.3
|
C14orf28
|
chromosome 14 open reading frame 28 |
chr14_+_53196872 | 0.36 |
ENST00000442123.2
ENST00000354586.4 |
STYX
|
serine/threonine/tyrosine interacting protein |
chr1_-_47134101 | 0.36 |
ENST00000576409.1
|
ATPAF1
|
ATP synthase mitochondrial F1 complex assembly factor 1 |
chr3_-_129325660 | 0.36 |
ENST00000324093.4
ENST00000393239.1 |
PLXND1
|
plexin D1 |
chr10_-_63213177 | 0.36 |
ENST00000399298.3
ENST00000399293.1 |
TMEM26
|
transmembrane protein 26 |
chr8_-_93115445 | 0.36 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr1_+_231297798 | 0.35 |
ENST00000444294.3
|
TRIM67
|
tripartite motif containing 67 |
chr4_+_95129061 | 0.35 |
ENST00000354268.4
|
SMARCAD1
|
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 |
chr12_+_54366894 | 0.35 |
ENST00000546378.1
ENST00000243082.4 |
HOXC11
|
homeobox C11 |
chr7_-_27219632 | 0.35 |
ENST00000470747.4
|
RP1-170O19.20
|
Uncharacterized protein |
chrX_-_129244655 | 0.35 |
ENST00000335997.7
|
ELF4
|
E74-like factor 4 (ets domain transcription factor) |
chr12_+_122516626 | 0.35 |
ENST00000319080.7
|
MLXIP
|
MLX interacting protein |
chr14_+_55518349 | 0.34 |
ENST00000395468.4
|
MAPK1IP1L
|
mitogen-activated protein kinase 1 interacting protein 1-like |
chr22_-_24093267 | 0.34 |
ENST00000341976.3
|
ZNF70
|
zinc finger protein 70 |
chr6_-_8064567 | 0.34 |
ENST00000543936.1
ENST00000397457.2 |
BLOC1S5
|
biogenesis of lysosomal organelles complex-1, subunit 5, muted |
chr2_+_119981384 | 0.34 |
ENST00000393108.2
ENST00000354888.5 ENST00000450943.2 ENST00000393110.2 ENST00000393106.2 ENST00000409811.1 ENST00000393107.2 |
STEAP3
|
STEAP family member 3, metalloreductase |
chr5_-_131563501 | 0.34 |
ENST00000401867.1
ENST00000379086.1 ENST00000418055.1 ENST00000453286.1 ENST00000166534.4 |
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
chr11_+_32112431 | 0.34 |
ENST00000054950.3
|
RCN1
|
reticulocalbin 1, EF-hand calcium binding domain |
chr17_-_38721711 | 0.34 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
chr5_-_146833485 | 0.33 |
ENST00000398514.3
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chr3_-_33138286 | 0.33 |
ENST00000416695.2
ENST00000342462.4 ENST00000399402.3 |
TMPPE
GLB1
|
transmembrane protein with metallophosphoesterase domain galactosidase, beta 1 |
chr13_-_95248511 | 0.33 |
ENST00000261296.5
|
TGDS
|
TDP-glucose 4,6-dehydratase |
chr12_-_56652111 | 0.33 |
ENST00000267116.7
|
ANKRD52
|
ankyrin repeat domain 52 |
chr21_+_42539701 | 0.33 |
ENST00000330333.6
ENST00000328735.6 ENST00000347667.5 |
BACE2
|
beta-site APP-cleaving enzyme 2 |
chr22_-_36236265 | 0.32 |
ENST00000414461.2
ENST00000416721.2 ENST00000449924.2 ENST00000262829.7 ENST00000397305.3 |
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr2_-_71221942 | 0.32 |
ENST00000272438.4
|
TEX261
|
testis expressed 261 |
chr18_-_30050395 | 0.32 |
ENST00000269209.6
ENST00000399218.4 |
GAREM
|
GRB2 associated, regulator of MAPK1 |
chr17_+_41476327 | 0.32 |
ENST00000320033.4
|
ARL4D
|
ADP-ribosylation factor-like 4D |
chr11_+_86748863 | 0.32 |
ENST00000340353.7
|
TMEM135
|
transmembrane protein 135 |
chr3_-_183273477 | 0.32 |
ENST00000341319.3
|
KLHL6
|
kelch-like family member 6 |
chr22_+_18043133 | 0.31 |
ENST00000327451.6
ENST00000399813.1 |
SLC25A18
|
solute carrier family 25 (glutamate carrier), member 18 |
chr21_+_45079409 | 0.31 |
ENST00000340648.4
|
RRP1B
|
ribosomal RNA processing 1B |
chr10_+_102106829 | 0.31 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
chr8_+_126442563 | 0.31 |
ENST00000311922.3
|
TRIB1
|
tribbles pseudokinase 1 |
chr1_+_101361626 | 0.31 |
ENST00000370112.4
|
SLC30A7
|
solute carrier family 30 (zinc transporter), member 7 |
chr18_+_21693306 | 0.31 |
ENST00000540918.2
|
TTC39C
|
tetratricopeptide repeat domain 39C |
chr1_+_164528866 | 0.31 |
ENST00000420696.2
|
PBX1
|
pre-B-cell leukemia homeobox 1 |
chr5_+_148206156 | 0.31 |
ENST00000305988.4
|
ADRB2
|
adrenoceptor beta 2, surface |
chr1_-_6295975 | 0.31 |
ENST00000343813.5
ENST00000362035.3 |
ICMT
|
isoprenylcysteine carboxyl methyltransferase |
chr1_+_161129254 | 0.31 |
ENST00000368002.3
ENST00000289865.8 ENST00000479344.1 ENST00000368001.1 |
USP21
|
ubiquitin specific peptidase 21 |
chr5_+_129240151 | 0.30 |
ENST00000305031.4
|
CHSY3
|
chondroitin sulfate synthase 3 |
chr14_+_55493920 | 0.30 |
ENST00000395472.2
ENST00000555846.1 |
SOCS4
|
suppressor of cytokine signaling 4 |
chr10_-_100027943 | 0.30 |
ENST00000260702.3
|
LOXL4
|
lysyl oxidase-like 4 |
chr14_-_75593708 | 0.30 |
ENST00000557673.1
ENST00000238616.5 |
NEK9
|
NIMA-related kinase 9 |
chr15_+_85359911 | 0.30 |
ENST00000258888.5
|
ALPK3
|
alpha-kinase 3 |
chr14_+_75348592 | 0.30 |
ENST00000334220.4
|
DLST
|
dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) |
chr3_+_119187785 | 0.29 |
ENST00000295588.4
ENST00000476573.1 |
POGLUT1
|
protein O-glucosyltransferase 1 |
chr7_+_138916231 | 0.29 |
ENST00000473989.3
ENST00000288561.8 |
UBN2
|
ubinuclein 2 |
chr6_-_86352642 | 0.29 |
ENST00000355238.6
|
SYNCRIP
|
synaptotagmin binding, cytoplasmic RNA interacting protein |
chr18_-_51751132 | 0.29 |
ENST00000256429.3
|
MBD2
|
methyl-CpG binding domain protein 2 |
chr12_-_57400227 | 0.29 |
ENST00000300101.2
|
ZBTB39
|
zinc finger and BTB domain containing 39 |
chr10_+_115614370 | 0.29 |
ENST00000369301.3
|
NHLRC2
|
NHL repeat containing 2 |
chr5_+_151151471 | 0.29 |
ENST00000394123.3
ENST00000543466.1 |
G3BP1
|
GTPase activating protein (SH3 domain) binding protein 1 |
chr8_+_21946681 | 0.28 |
ENST00000289921.7
|
FAM160B2
|
family with sequence similarity 160, member B2 |
chr13_+_49550015 | 0.28 |
ENST00000492622.2
|
FNDC3A
|
fibronectin type III domain containing 3A |
chr3_+_171758344 | 0.28 |
ENST00000336824.4
ENST00000423424.1 |
FNDC3B
|
fibronectin type III domain containing 3B |
chr13_-_110438914 | 0.28 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
chr9_-_74383799 | 0.28 |
ENST00000377044.4
|
TMEM2
|
transmembrane protein 2 |
chr6_-_3457256 | 0.28 |
ENST00000436008.2
|
SLC22A23
|
solute carrier family 22, member 23 |
chr12_-_49449107 | 0.27 |
ENST00000301067.7
|
KMT2D
|
lysine (K)-specific methyltransferase 2D |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 4.1 | GO:0044691 | tooth eruption(GO:0044691) |
0.5 | 1.4 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.5 | 1.8 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.4 | 1.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.4 | 1.6 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.4 | 1.1 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.4 | 1.5 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.4 | 1.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 1.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 2.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.3 | 2.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 1.3 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 0.9 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.2 | 0.7 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
0.2 | 1.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.2 | 0.6 | GO:0034059 | response to anoxia(GO:0034059) |
0.2 | 0.6 | GO:0002605 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of dendritic cell antigen processing and presentation(GO:0002605) |
0.2 | 0.9 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.2 | 0.7 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.5 | GO:1903249 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.2 | 0.9 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.2 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.2 | 0.9 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.2 | 0.7 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.2 | 0.5 | GO:1904316 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.2 | 0.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 1.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 0.4 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 0.4 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.1 | 0.9 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.4 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
0.1 | 0.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.4 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.1 | 0.9 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.6 | GO:0021836 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.1 | 0.3 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) regulation of dendritic cell dendrite assembly(GO:2000547) |
0.1 | 0.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 2.7 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.1 | 0.6 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
0.1 | 1.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.6 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.1 | 0.3 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.3 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.1 | 0.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.8 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.2 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.1 | 0.1 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.3 | GO:0051413 | response to cortisone(GO:0051413) |
0.1 | 0.2 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.1 | 1.2 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.8 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.1 | 0.2 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.1 | 0.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.9 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 2.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.2 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.1 | 0.4 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.8 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 0.6 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.1 | 0.2 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 0.8 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.1 | 0.2 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.3 | GO:0051414 | response to cortisol(GO:0051414) |
0.1 | 0.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.0 | 0.1 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.0 | 0.1 | GO:0034147 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
0.0 | 0.3 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.0 | 0.5 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.0 | 0.6 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.3 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.0 | 0.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.5 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 0.3 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.0 | 1.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.3 | GO:0030047 | actin modification(GO:0030047) |
0.0 | 0.3 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.0 | 0.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.0 | 1.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.2 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.0 | 0.5 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.1 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.0 | 0.1 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.0 | 0.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.1 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.0 | 0.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.2 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.0 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.0 | 0.7 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.4 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.0 | 1.5 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.6 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.0 | 0.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.1 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.0 | 0.2 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.0 | 0.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.0 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.0 | 0.2 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.0 | 0.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.2 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.1 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.0 | 0.1 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.1 | GO:1990926 | vesicle-mediated cholesterol transport(GO:0090119) short-term synaptic potentiation(GO:1990926) |
0.0 | 0.6 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.1 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.8 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.1 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.0 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.0 | 0.2 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.6 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.4 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.0 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.1 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.0 | 0.1 | GO:0015677 | copper ion import(GO:0015677) |
0.0 | 0.6 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.3 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.0 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.1 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.1 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.0 | 0.7 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.0 | 0.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.0 | 0.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.0 | 0.2 | GO:1990440 | ATF6-mediated unfolded protein response(GO:0036500) positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
0.0 | 0.1 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.4 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
0.0 | 0.0 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.0 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.4 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.8 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 0.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.1 | GO:1902022 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
0.0 | 0.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.2 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.2 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.6 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.0 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.0 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.0 | 0.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 1.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.1 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.9 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.1 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.1 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.7 | 2.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.4 | 1.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 2.9 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 3.4 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.3 | 0.8 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 1.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 1.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.4 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.2 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 0.2 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.0 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.0 | 0.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.4 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 0.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 0.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.6 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 1.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 2.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.1 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 1.3 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 1.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.0 | GO:0060187 | cell pole(GO:0060187) |
0.0 | 2.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 1.8 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.6 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 1.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 1.7 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.3 | 7.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 0.9 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.3 | 0.9 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
0.3 | 1.5 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.2 | 0.7 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 0.5 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.2 | 0.5 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.2 | 1.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.4 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.1 | 0.5 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.1 | 0.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) collagen V binding(GO:0070052) |
0.1 | 0.6 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.1 | 0.3 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 0.6 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.1 | 0.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 1.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.2 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.1 | 0.2 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.2 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.1 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) PTB domain binding(GO:0051425) |
0.1 | 1.6 | GO:0070330 | aromatase activity(GO:0070330) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 2.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.9 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.1 | 0.2 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.1 | 1.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 2.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.2 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.3 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
0.0 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 1.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.6 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 3.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.4 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.6 | GO:0017111 | nucleoside-triphosphatase activity(GO:0017111) |
0.0 | 4.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 1.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.7 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.3 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.0 | 1.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.2 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.2 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.0 | 0.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.2 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.0 | 0.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.0 | 0.2 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.3 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
0.0 | 0.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.1 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.0 | 0.1 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.0 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.0 | 0.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.1 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
0.0 | 0.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.0 | 0.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.1 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.0 | 0.8 | GO:0005518 | collagen binding(GO:0005518) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 11.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 2.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 2.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.9 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 1.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 1.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 5.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.0 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 6.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 2.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.9 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 1.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.4 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |